Upcoming COCA Call: May 24: Potential for Falsely Low Blood Lead Test Results from LeadCare® Analyzers

On May 17, 2017, the U.S. Food and Drug Administration (FDA) issued a safety communication warning about the use of Magellan Diagnostics’ LeadCare® analyzers with venous blood samples because they might result in falsely low test results. FDA is now advising that Magellan Diagnostics’ LeadCare® analyzers should no longer be used with venous blood samples. The safety alert does not apply to capillary blood lead test results collected by fingerstick of heelstick. During this COCA call, clinicians will learn the importance of lead testing for children and pregnant or lactating women, which patients may be impacted, and CDC’s recommendations for re-testing.

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2qJ3595
via IFTTT